Related Experiment Video
Updated: Nov 19, 2025

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for
Zhongping Shi1, Jun Wang, Shanjiang Chen
1Wenzhou Central Hospital, Wenzhou, Zhejiang Province, China.
Insights
This study systematically evaluates the association between the angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism and arteriosclerosis. Findings will clarify the genetic basis of arteriosclerosis, aiding in understanding its hereditary nature.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- Arteriosclerosis exhibits a genetic correlation, with the angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism frequently linked to the condition.
- Existing evidence for this association lacks a robust evidence-based foundation.
- This systematic review aims to consolidate and evaluate the existing data.
Purpose of the Study:
- To systematically evaluate the relationship between the AT1R gene A1166C polymorphism and arteriosclerosis.
- To provide an evidence-based foundation for understanding the genetic predisposition to arteriosclerosis.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (CNKI, Wanfang, VIP, CBM, PubMed, EMBASE, Web of Science, Cochrane Library) up to December 2020.
- Included observational studies (case-control, cross-sectional, cohort) in English and Chinese were assessed for quality by two independent researchers.
- Statistical analysis was performed using Stata 16.0 software.
Main Results:
- Pulse wave velocity will be utilized as a key indicator for assessing arteriosclerosis.
- The study will analyze the correlation between the AT1R gene A1166C polymorphism and arteriosclerosis using collected data.
Conclusions:
- This systematic review will offer evidence-based insights into the genetic factors contributing to arteriosclerosis.
- The findings are expected to enhance the understanding of the hereditary components of arteriosclerosis.
Background:
Arteriosclerosis has genetic correlation. Many studies have shown that angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism is highly associated with arteriosclerosis, but there is no evidence-based basis. The purpose of this study is to systematically evaluate the relationship between AT1R gene A1166C polymorphism and arteriosclerosis.
Methods:
The search time is set from the establishment of the database in December 2020 in this study. The search database include China National Knowledge Infrastructure (CNKI), Wanfang, VIP and China Biology Medicine disc (CBM), PubMed, EMBASE, Web of Science, and the Cochrane Library. The subjects are observational studies on the relationship between AGTR1 A1166C polymorphism and arteriosclerosis (including case-control study, cross-sectional study, and cohort study). The language is limited to English and Chinese. The data of the included study are extracted and the literature quality is evaluated by 2 researchers independently. The data are statistically analyzed by Stata 16.0 software.
Results:
This study will use pulse wave velocity as an index to evaluate arteriosclerosis to explore the relationship between AT1R gene A1166C polymorphism and arteriosclerosis.
Conclusion:
This study will provide evidence-based medicine for elucidating the genetic tendency of arteriosclerosis.
Ethics And Dissemination:
Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.
Osf Registration Number:
DOI 10.17605/OSF.IO/V6E2Y.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of β1 Blockers

